These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23982212)

  • 1. Combination of pharmacophore hypothesis, genetic function approximation model, and molecular docking to identify novel inhibitors of S6K1.
    Zhang H; Xiang ML; Liang JY; Zeng T; Zhang XN; Zhang J; Yang SY
    Mol Divers; 2013 Nov; 17(4):767-72. PubMed ID: 23982212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach.
    Alam A; Khan MS; Mathur Y; Sulaimani MN; Farooqui N; Ahmad SF; Nadeem A; Yadav DK; Mohammad T
    J Biomol Struct Dyn; 2024 Jul; 42(11):5758-5769. PubMed ID: 37365756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel S6K1 inhibitors by an ensemble-based virtual screening method and molecular dynamics simulation.
    Zhang H; Zhang HR; Zhang J; Hu ML; Ren L; Luo QQ; Qi HZ
    J Mol Model; 2023 Mar; 29(4):102. PubMed ID: 36933164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer.
    Nam KH; Yi SA; Nam G; Noh JS; Park JW; Lee MG; Park JH; Oh H; Lee J; Lee KR; Park HJ; Lee J; Han JW
    BMC Cancer; 2019 Aug; 19(1):773. PubMed ID: 31387554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel Bruton's tyrosine kinase inhibitors using a hybrid protocol of virtual screening approaches based on SVM model, pharmacophore and molecular docking.
    Wan HL; Wang ZR; Li LL; Cheng C; Ji P; Liu JJ; Zhang H; Zou J; Yang SY
    Chem Biol Drug Des; 2012 Sep; 80(3):366-73. PubMed ID: 22594639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CK2 inhibitors with new scaffolds by a hybrid virtual screening approach based on Bayesian model; pharmacophore hypothesis and molecular docking.
    Di-wu L; Li LL; Wang WJ; Xie HZ; Yang J; Zhang CH; Huang Q; Zhong L; Feng S; Yang SY
    J Mol Graph Model; 2012 Jun; 36():42-7. PubMed ID: 22516037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of organometallic S6K1 inhibitors.
    Qin J; Rajaratnam R; Feng L; Salami J; Barber-Rotenberg JS; Domsic J; Reyes-Uribe P; Liu H; Dang W; Berger SL; Villanueva J; Meggers E; Marmorstein R
    J Med Chem; 2015 Jan; 58(1):305-14. PubMed ID: 25356520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Toxoplasma gondii virulence factor ROP18 competitive inhibitors by virtual screening.
    Yin K; Zhao G; Xu C; Qiu X; Wen B; Sun H; Liu G; Liu Y; Zhao Q; Wei Q; Huang B; Yan G; Cao J
    Parasit Vectors; 2019 Mar; 12(1):98. PubMed ID: 30867024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel focal adhesion kinase inhibitors using a hybrid protocol of virtual screening approach based on multicomplex-based pharmacophore and molecular docking.
    Wu F; Xu T; He G; Ouyang L; Han B; Peng C; Song X; Xiang M
    Int J Mol Sci; 2012 Nov; 13(12):15668-78. PubMed ID: 23443087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.
    Sharma A; Thelma BK
    J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of the S6K1 kinase domain in complexes with inhibitors.
    Niwa H; Mikuni J; Sasaki S; Tomabechi Y; Honda K; Ikeda M; Ohsawa N; Wakiyama M; Handa N; Shirouzu M; Honma T; Tanaka A; Yokoyama S
    J Struct Funct Genomics; 2014 Sep; 15(3):153-64. PubMed ID: 25078151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel anaplastic lymphoma kinase (ALK) inhibitors using a common feature pharmacophore model derived from known ligands crystallized with ALK.
    Xie HZ; Lan H; Pan YL; Zou J; Wang ZR; Li LL; Huang Q; Zhang H; Yang SY
    Chem Biol Drug Des; 2013 Feb; 81(2):175-84. PubMed ID: 23107363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel FAK and S6K1 dual inhibitors from natural compounds via ADMET screening and molecular docking.
    Thiyagarajan V; Lin SH; Chang YC; Weng CF
    Biomed Pharmacother; 2016 May; 80():52-62. PubMed ID: 27133039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of ribosomal protein S6 kinase 1 at Thr421/Ser424 and dephosphorylation at Thr389 regulates SP600125-induced polyploidization of megakaryocytic cell lines.
    Li CL; Yang JG; Lin D; Zhao YS; Liu S; Xing SN; Zhao S; Chen CQ; Jiang ZM; Pu FF; Cao JP; Ma DC
    PLoS One; 2014; 9(12):e114389. PubMed ID: 25486532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors.
    Xie HZ; Li LL; Ren JX; Zou J; Yang L; Wei YQ; Yang SY
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1944-9. PubMed ID: 19254842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Novel GSK-3β Inhibitors Using Pharmacophore and Virtual Screening Studies.
    Balakrishnan N; Raj JS; Kandakatla N
    Interdiscip Sci; 2016 Sep; 8(3):303-11. PubMed ID: 26298578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).
    Pearce LR; Alton GR; Richter DT; Kath JC; Lingardo L; Chapman J; Hwang C; Alessi DR
    Biochem J; 2010 Oct; 431(2):245-55. PubMed ID: 20704563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations.
    Zhang Y; Zhang TJ; Tu S; Zhang ZH; Meng FH
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32911607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel and selective CDK4/6 inhibitors by pharmacophore and structure-based virtual screening.
    Yuan K; Min W; Wang X; Li J; Kuang W; Zhang F; Xie S; Yang P
    Future Med Chem; 2020 Jun; 12(12):1121-1136. PubMed ID: 32400188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.